Establishment of a Scalable Stable Lentivirus Manufacturing Process in Suspension Perfusion Mode

被引：0
|
作者：
Laux, Holger [1 ]
Klimpel, Maximilian [1 ]
Lal, Nikki Indresh [1 ]
Arrizabalagacascallana, Marta [2 ]
Pirzas, Vicky [1 ]
机构：
[1] CSL Behring Innovat GmbH, Marburg, Germany
[2] UCL, London, England
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
413
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [1] Development of a perfusion process for continuous lentivirus production using stable suspension producer cell lines
    Klimpel, Maximilian
    Terrao, Monica
    Ching, Nilakshi
    Climenti, Vanessa
    Noll, Thomas
    Pirzas, Vicky
    Laux, Holger
    BIOTECHNOLOGY AND BIOENGINEERING, 2023, 120 (09) : 2622 - 2638
  • [2] Establishment of a Scalable Production Process Using Stable Helper-Virus Free AAV Producer Cell Lines Based on Human Suspension Cells
    Hein, Kerstin
    Goncalves, Ines do Carmo
    Strempel, Nikola
    Woelfel, Jens
    Niehus, Christian
    Hudjetz, Ben
    Riebesehl, Nina
    Kewes, Helmut
    Bauer, Thu
    Jamaladin, Israa
    Patil, Aishwarya
    Al-Dali, Ahmad
    Bialek, Corinna
    Coronel, Juliana
    Wissing, Silke
    Faust, Nicole
    MOLECULAR THERAPY, 2020, 28 (04) : 204 - 205
  • [3] Development of a Scalable Lentiviral Manufacturing Upstream Process with a Suspension Producer Line for Cell Therapy Applications
    Strasser, Kimchi A.
    Pertl, Anja
    Bauer, Jana
    Huber, Georg
    Volkmann, Bianca
    Ferreira, Irene
    Salomon, Michael
    MOLECULAR THERAPY, 2023, 31 (04) : 153 - 153
  • [4] ESTABLISHMENT OF A SUSPENSION -BASED PERFUSION PROCESS FOR THE EFFECTIVE PRODUCTION OF LENTIVIRUSES USING INDUCIBLE PRODUCER CELL LINES
    Cascallana, M. Arrizabalaga
    Klimpel, M.
    Goldrick, S.
    Laux, H.
    Rafiq, Q. A.
    CYTOTHERAPY, 2024, 26 (06) : S206 - S207
  • [5] Generation of stable suspension producer cell lines for serum-free lentivirus production
    Klimpel, Maximilian
    Terrao, Monica
    Braeuer, Melina
    Dersch, Herbert
    Biserni, Martina
    Do Nascimento, Larissa Melo
    Schwingal, Sarah
    Vogel, Jessica E.
    Ferlemann, Cathrin
    Brandt, Tobias
    Lal, Nikki Indresh
    Bridgeman, Krystal
    Petzke, Alex
    McDwyer, Eva
    Lim, Jo Leen
    Oh, Seungyoul
    Brumatti, Gabriela
    Minambres, Albert Garcia
    Otte, Ellen
    Noll, Thomas
    Pirzas, Vicky
    Laux, Holger
    BIOTECHNOLOGY JOURNAL, 2024, 19 (05)
  • [6] Lentivirus Manufacturing Process for Primary T-Cell Biofactory Production
    Radhakrishnan, Harikrishnan
    Javitz, Harold S.
    Bhatnagar, Parijat
    ADVANCED BIOSYSTEMS, 2020, 4 (06)
  • [7] Transitioning from Adherent to Optimized and Scalable Suspension-Based Production of CAR-Lentivirus (LV)
    Maystrenko, Anna
    Mcleod, Adam
    Chettiar, Daniel
    Sudarsan, Arun Kumar Annan
    Beaudette, Philip
    Al Asafen, Hadel
    Kawka, Karina
    Razvi, Azher
    McNally, Krista
    Gacerez, Albert
    Fardy, Melissa
    MOLECULAR THERAPY, 2023, 31 (04) : 547 - 547
  • [8] ESTABLISHMENT OF A RADIATION HARDENED CMOS MANUFACTURING PROCESS
    LONDON, A
    MATTEUCCI, DA
    WANG, RC
    IEEE TRANSACTIONS ON NUCLEAR SCIENCE, 1977, 24 (06) : 2056 - 2059
  • [9] XLenti Stable Cell Lines for Lentivirus Manufacturing: New Development, Characterisation, and Future Goals
    Branciaroli, Corinne
    MOLECULAR THERAPY, 2021, 29 (04) : 392 - 392
  • [10] A small-scale perfusion based hollow-fiber bioreactor supports a scalable T cell manufacturing process
    Miller, M.
    Knaub, M.
    Fabre, H.
    Frank, N.
    Jarabo, P.
    Sethi, D.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A165 - A166
12345